# Vaccine Therapy in Treating Patients With Non-Metastatic Prostate Cancer

> **NCT00814892** · PHASE2 · TERMINATED · sponsor: **Mayo Clinic** · enrollment: 2 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **BIOLOGICAL:** allogeneic tumor cell vaccine
- **BIOLOGICAL:** therapeutic autologous dendritic cells

## Key facts

- **NCT ID:** NCT00814892
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-01
- **Primary completion:** 2009-12
- **Final completion:** 2010-03
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** Study was terminated due to funding issues.
- **Last updated:** 2013-11-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00814892

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00814892, "Vaccine Therapy in Treating Patients With Non-Metastatic Prostate Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00814892. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*